Ivy leaf dry extract EA 575 for the treatment of acute and chronic cough in pediatric patients: review and expert survey

References

• European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC). Assessment report on Hedera helix L. folium. 2017; EMA/HMPC/325715/2017.
   Google Scholar
• Prospan® cough syrup. Package leaflet. Germany: Engelhard Arzneimittel GmbH & Co. KG; October 2018.
   Google Scholar
• Lang C, Röttger-Lüer P, Staiger C. A valuable option for the treatment of respiratory diseases: review on the clinical evidence of the ivy leaves dry extract EA 575®. Planta Med. 2015;81(12–13):968–974. doi: 10.1055/s-0035-1545879.
   PubMed Web of Science ®Google Scholar
• Reckhenrich AK, Klüting A, Veit M. Ivy leaf extracts for the treatment of respiratory tract diseases accompanied by cough: a systematic review of clinical trials. HerbalGram. 2018;117:58–71.
   Google Scholar
• Wichtl M (ed). Hederae folium. In: Herbal drugs and phytopharmaceuticals, 3rd ed. Stuttgart: medPharm GmbH Scientific Publishers; 2004. p. 274–277.
   Google Scholar
• Greunke C, Hage-Hülsmann A, Sorkalla T, et al. A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther. 2015;31:92–98. doi: 10.1016/j.pupt.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Sieben A, Prenner L, Sorkalla T, et al. α-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of β2-adrenergic receptors. Biochemistry. 2009;48(15):3477–3482. doi: 10.1021/bi802036b.
   PubMed Web of Science ®Google Scholar
• Wolf A, Gosens R, Meurs H, et al. Pre-treatment with α-hederin increases β-adrenoceptor mediated relaxation of airway smooth muscle. Phytomedicine. 2011;18(2–3):214–218. doi: 10.1016/j.phymed.2010.05.010.
   PubMed Web of Science ®Google Scholar
• Meurer F, Schulte-Michels J, Häberlein H, et al. Ivy leaves dry extract EA 575® mediates biased β2-adrenergic receptor signaling. Phytomedicine. 2021;90:153645. doi: 10.1016/j.phymed.2021.153645.
   PubMed Web of Science ®Google Scholar
• Proskocil BJ, Fryer AD. B2-agonist and anticholinergic drugs in the treatment of lung disease. Proc Am Thorac Soc. 2005;2(4):305–310. doi: 10.1513/pats.200504-038SR.
   PubMedGoogle Scholar
• Anzueto A, Jubran A, Ohar JA, et al. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA. 1997;278(17):1426–1431. doi: 10.1001/jama.1997.03550170056032.
   PubMed Web of Science ®Google Scholar
• Button B, Goodell HP, Atieh E, et al. Roles of mucus adhesion and cohesion in cough clearance. Proc Natl Acad Sci USA. 2018;115(49):12501–12506. doi: 10.1073/pnas.1811787115.
   PubMed Web of Science ®Google Scholar
• Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airways disease. Eur Respir J. 1997;10(2):482–491. doi: 10.1183/09031936.97.10020482.
   PubMed Web of Science ®Google Scholar
• Rubin BK, Ramirez O, King M. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest. 1992;101(4):1080–1085. doi: 10.1378/chest.101.4.1080.
   PubMed Web of Science ®Google Scholar
• Schulte-Michels J, Runkel F, Gokorsch S, et al. Ivy leaves dry extract EA 575® decreases LPS-induced IL-6 release from murine macrophages. Pharmazie. 2016;71(3):158–161. doi: 10.1691/ph.2016.5835.
   PubMed Web of Science ®Google Scholar
• Schulte-Michels J, Keksel C, Häberlein H, et al. Anti-inflammatory effects of ivy leaves dry extract: influence on transcriptional activity of NFκB. Inflammopharmacology. 2019;27(2):339–347. doi: 10.1007/s10787-018-0494-9.
   PubMed Web of Science ®Google Scholar
• Völp A, Schmitz J, Bulitta M, et al. Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials. Sci Rep. 2022;12(1):20041. doi: 10.1038/s41598-022-24393-1.
   PubMedGoogle Scholar
• Vogelberg C, Cuevas Schacht F, Watling CP, et al. Therapeutic principles and unmet needs in the treatment of cough in pediatric patients: review and expert survey. BMC Pediatr. 2023;23(1):34. doi: 10.1186/s12887-022-03814-0.
   PubMed Web of Science ®Google Scholar
• Gulyas A, Repges R, Dethlefsen U. Consequent therapy of chronic obstructive respiratory tract illnesses in children. Atemw Lungenkrkh. 1997;5:291–294. [Translated title]
   Google Scholar
• Mansfeld HJ, Höhre H, Repges R, et al. Sekretolyse und bronchospasmolyse. TW Pädiatrie. 1997;10(3):155–157.
   Google Scholar
• Mansfeld HJ, Höhre H, Repges R, et al. Therapie des Asthma bronchiale mit Efeublätter-Trockenextrakt. Munch Med Wochenschr. 1998;140(3):26–30.
   Google Scholar
• Gulyas A. Efeublätter-Extrakt zeigt bei Kindern mit chronisch obstruktiven Atemwegserkrankungen vergleichbare Effekte wie Acetylcystein. 1999; [cited 2023 Feb 1]. Available from: https://phytokompass.de/efeublaetter-extrakt-zeigt-bei-kindern-mit-chronisch-obstruktiven-atemwegserkrankungen-vergleichbare-effekte-wie-acetylcystein/.
   Google Scholar
• Unkauf M, Friederich M. Bronchitis bei kindern: klinische studie mit Efeublätter-Trockenextrakt. Der Bayerische Internist. 2000;4:1–4.
   Google Scholar
• Maidannik V, Duka E, Kachalova O, et al. Efficacy of prospan application in children’s diseases of respiratory tract. Pediatr Tocol Gyn. 2003;4:1–7.
   Google Scholar
• Bolbot Y, Prokhorov E, Mokia S, et al. Comparing the efficacy and safety of high-concentrate (5–7.5:1) ivy leaves extract and acetylcysteine for treatment of children with acute bronchitis. Drugs of Ukraine. 2004;11:1–4. [Translated title]
   Google Scholar
• Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 2011;18(13):1105–1109. doi: 10.1016/j.phymed.2011.06.014.
   PubMed Web of Science ®Google Scholar
• EU. Clinical Trials Register (2007-003272-19); [cited 2023 Feb 1]. Available from: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-003272-19.
   Google Scholar
• Zeil S, Schwanebeck U, Vogelberg C. Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma. Phytomedicine. 2014;21(10):1216–1220. doi: 10.1016/j.phymed.2014.05.006.
   PubMed Web of Science ®Google Scholar
• Lässig W, Generlich H, Heydolph F, et al. Wirksamkeit und Verträglichkeit efeuhaltiger Hustenmittel. TW Pädiatrie. 1996;9:489–491.
   Google Scholar
• Hecker M. Wirksamkeit und Verträglichkeit von Efeuextrakt bei Patienten mit atemwegserkrankungen. Natura Med. 1999;14(2):28–33.
   Google Scholar
• Hecker M, Runkel F, Völp A. Behandlung chronischer Bronchitis mit einem Spezialextrakt aus Efeublättern – multizentrische Anwendungsbeobachtung mit 1350 patienten. Forsch Komplementärmed Klass Naturheilkd. 2002;9:77–84. doi: 10.1159/000057269.
   PubMedGoogle Scholar
• Kraft K. Verträglichkeit von Efeublättertrockenextrakt im Kindesalter. Z Phytother. 2004;25:179–181.
   Google Scholar
• Fazio S, Pouso J, Dolinsky D, et al. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine. 2009;16(1):17–24. doi: 10.1016/j.phymed.2006.05.003.
   PubMed Web of Science ®Google Scholar
• Beden AB, Perko J, Terčelj R, et al. Potek zdravljenja akutne okužbe dihal pri slovenskih otrocih s sirupom, ki vsebuje izvleček listov bršljana. Zdrav Vestn. 2011;80:276–284.
   Google Scholar
• Stauss-Grabo M, Atiye S, Warnke A, et al. Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan® cough tablets) in the treatment of colds accompanied by coughing. Phytomedicine. 2011;18(6):433–436. doi: 10.1016/j.phymed.2010.11.009.
   PubMed Web of Science ®Google Scholar
• Lang C, Staiger C, Wegener T. Efeu in der pädiatrischen Praxis: Anwendung von EA 575® in der Therapie der akuten Bronchitis bei Schulkindern. Z Phytother. 2015;36(05):192–196. doi: 10.1055/s-0041-105237.
   Google Scholar
• Kruttschnitt E, Wegener T, Zahner C, et al. Assessment of the efficacy and safety of ivy leaf (Hedera helix) cough syrup compared with acetylcysteine in adults and children with acute bronchitis. Evid Based Complement Alternat Med. 2020;2020:1910656. doi: 10.1155/2020/1910656.
   PubMed Web of Science ®Google Scholar
• Barnes LAJ, Leach M, Anheyer D, et al. The effects of Hedera helix on viral respiratory infections in humans: a rapid review. Adv Integr Med. 2020;7(4):222–226. doi: 10.1016/j.aimed.2020.07.012.
   PubMed Web of Science ®Google Scholar
• Sierocinski E, Holzinger F, Chenot JF. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol. 2021;77(8):1113–1122. doi: 10.1007/s00228-021-03090-4.
   PubMed Web of Science ®Google Scholar
• Shields MD, Bush A, Everard ML, et al; British Thoracic Society Cough Guideline Group. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax. 2008;63(Suppl 3):iii1–iii15. doi: 10.1136/thx.2007.077370.
   PubMedGoogle Scholar
• De Blasio F, Dicpinigaitis PV, Rubin BK, et al. An observational study on cough in children: epidemiology, impact on quality of sleep and treatment outcome. Cough. 2012;8(1):1. doi: 10.1186/1745-9974-8-1.
   PubMedGoogle Scholar
• Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–310. doi: 10.1097/PRS.0b013e318219c171.
   PubMed Web of Science ®Google Scholar
• Blonde L, Khunti K, Harris SB, et al. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763–1774. doi: 10.1007/s12325-018-0805-y.
   PubMed Web of Science ®Google Scholar
• Roche N, Anzueto A, Bosnic Anticevich S, et al. Respiratory effectiveness group collaborators. The importance of real-life research in respiratory medicine: manifesto of the respiratory effectiveness group. Eur Respir J. 2019;54(3):1901511. doi: 10.1183/13993003.01511-2019.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA). Should you give kids medicine for coughs and colds? FDA. October 2021; [cited 2023 Feb 1]. Available from: https://www.fda.gov/consumers/consumer-updates/should-you-give-kids-medicine-coughs-and-colds.
   Google Scholar
• Dicpinigaitis PV. Cough: an unmet clinical need. Br J Pharmacol. 2011;163(1):116–124. doi: 10.1111/j.1476-5381.2010.01198.x.
   PubMed Web of Science ®Google Scholar
• Eccles R. The powerful placebo effect in cough: relevance to treatment and clinical trials. Lung. 2020;198(1):13–21. doi: 10.1007/s00408-019-00305-5.
   PubMed Web of Science ®Google Scholar
• The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2023 report; [cited 2023 Feb 2]. Available from: https://goldcopd.org/2023-gold-report-2/#.
   Google Scholar
• Deolmi M, Decarolis NM, Motta M, et al. Early origins of chronic obstructive pulmonary disease: prenatal and early life risk factors. Int J Environ Res Public Health. 2023;20(3):2294. doi: 10.3390/ijerph20032294.
   PubMedGoogle Scholar
• Seed L, Wilson D, Coates AL. Children should not be treated like little adults in the PFT lab. Respir Care. 2012;57(1):61–74. doi: 10.4187/respcare.01430.
   PubMed Web of Science ®Google Scholar
• Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;2014(11):CD001831. doi: 10.1002/14651858.CD001831.pub5.
   PubMedGoogle Scholar